Table 2.
Indication | Recommendation | Strength of recommendation |
---|---|---|
Acute rhinosinusitis and common cold (ARS) | ||
EPOS 2020 for adults and children [1] | NSI possibly has benefits for symptom relief mainly in children | Ib# |
EPOS 2020 for adults with acute post-viral rhinosinusitis [1] | No recommendation can be given based on very low quality of evidence | |
EPOS 2020 for adults with acute bacterial rhinosinusitis [1] | No recommendation can be given based on very low quality of evidence | |
Finnish Guideline: ARS and common cold [11] | No mention of NSI | |
Allergic rhinitis (AR) | ||
ARIA 2008 [3] | Recommended in a pharmacy setting | |
Finnish guideline: AR [12] | No mention of NSI | |
AAFP Clinical Practice Guideline: AR 2015 [13] | No mention of NSI | |
Asthma | ||
Global initiative for asthma (GINA) [14] | No mention of NSI | |
Finnish guideline: Asthma [15] | No mention of NSI | |
International ERS/ATS guideline for asthma [16] | No mention of NSI | |
Atrophic rhinitis | ||
Finnish guideline: Atrophic rhinitis [17] | Recommended | |
Chronic sinusitis (CRS) | ||
EPOS 2020 for adults with chronic rhinosinusitis [1] | Recommended | Ia* |
EPOS 2020 for children with chronic rhinosinusitis [1] | Recommended | Ib+# |
Finnish guideline: CRS [11]* | Recommended | Low |
Post-operative care after functional endoscopic sinus surgery (FESS) | ||
No official guidelines exist | ||
Regular cleaning after FESS | ||
No official guidelines exist |
Note. EPOS 2020 reports the level of evidence instead of strength of recommendation.
*Based on older Cochrane reviews, *Ia: based on systematic review of RCTs; #Ib: based on individual RCT.